Lexaria Bioscience Corp. (LEXX)

0.66 +0.04 (+6.52%) USD  |  NASDAQ  |  Jun 04, 11:55
More

Lexaria Bioscience Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Pharmagreen Biotech, Inc. Upgrade
Target Group, Inc. (Canada) Upgrade
InMed Pharmaceuticals, Inc. Upgrade
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade